Fintel reports that on January 8, 2025, HSBC downgraded their outlook for Advanced Micro Devices (NasdaqGS:AMD) from Buy to ...

HSBC lowered its rating on Advanced Micro Devices stock amid several concerns including the chipmaker's ability to compete ...

In a report released today, Mark Lipacis from Evercore ISI maintained a Buy rating on Advanced Micro Devices (AMD – Research Report), with a ...

We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...

Advanced Micro Devices lags Nvidia in AI design wins, prompting a downgrade to sell. See why AMD stock faces little room to ...

Advanced Micro Devices shares fell Wednesday after HSBC analysts gave the stock a double downgrade, citing concerns about its artificial intelligence revenue.

Absci (ABSI) was rising after a media report on a $20M investment by the semiconductor company Advanced Micro Devices (AMD) in the AI drug creation company.

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

HSBC analyst Frank Lee sees that trend continuing, and lowered his price target on AMD shares by $90, to $110 per share, and ...

Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. The stock was up 27% to $3.89 in pre-market trading. Through Tuesday's close, shares ...